Document:

EXHIBIT 10.2

                       SHARE-FOR-SHARE EXCHANGE AGREEMENT

SHARE-FOR-SHARE EXCHANGE AGREEMENT made this ___ day of August, 2005 by and
among WEBB MORTGAGE DEPOT, INC. a Florida corporation (the "Corporation"), BYRON
WEBB ("Webb"), and MEDICAL CONNECTIONS, INC., a Florida Corporation ("Medical"),
together with each of the Medical Shareholders (as hereinafter defined).

                                    RECITALS:

A. The Corporation has offered to issue 444,600 shares of its common stock,
$.001 par value (the "Common Stock), to the holders of shares of the capital
stock of Medical (the "Medical Shareholders") in exchange for their contribution
to the Corporation of all of the issued and outstanding capital stock of Medical
(the "Medical Shares").

B. The respective Boards of Directors of the Corporation and Medical have
determined that, subject to the terms, conditions, agreements, representations
and warranties set forth herein, the exchange contemplated herein will serve the
general welfare and advantage of their respective businesses.

C. Subject to the terms and conditions set forth herein, the Medical
Shareholders desire to contribute all of the shares of Medical capital stock for
shares of Common Stock in the manner hereinafter set forth herein.

D. The exchange is intended to comply with the requirements of Section 368 of
the Internal Revenue Code of 1986, as amended, the Treasury Regulations
promulgated thereunder and the interpretive rulings issued pursuant thereto.

NOW, THEREFORE, in consideration of the foregoing recitals, as well as the
mutual covenants hereinafter set forth, the parties hereto, intending to be
legally bound, hereby agree as follows:

                                    ARTICLE I
                               EXCHANGE PROVISIONS

         1.1       Contribution.

Subject to the terms and conditions hereinafter set forth:

                  (a) Each Medical Shareholder agrees to contribute, transfer,
assign and convey at Closing all of their Medical Shares to the Corporation,
together with all other rights, claims and interests he or she may have with
respect to Medical or its respective assets, and all claims he may have against
its officers and directors, including, but not limited to, all rights to unpaid
dividends and all claims and causes of action arising from or in connection with

<PAGE>

the ownership of Medical Shares or its issuance, excluding any right, claim or
interest of same arising under this Agreement or in connection with the
transaction contemplated by this Agreement. Each Medical Shareholder shall
deliver to Medical all of his stock certificates representing the Medical
Shares, together with a stock power therefore, duly executed in blank, to be
held by Medical for delivery at Closing; and

                  (b) The Corporation agrees to issue to each Medical
Shareholder the Shareholder's pro rata portion of the total number of shares to
be issued to the Medical Shareholders.

Schedule 1.1 will set forth the name of each Medical Shareholder, the number of
shares each owns as of the date of this Agreement and the number of shares of
Common Stock each will receive at Closing.

         1.2       Byron Webb.

                  (a) At Closing, Medical shall pay to Webb $200,000 and Webb
shall surrender to the Corporation for cancellation a total of 1,831,000 Shares
of capital stock he owns in the Corporation, said shares representing all of the
issued and outstanding shares of the Corporation owned by Webb at Closing.

         1.        No Registration.

                   (a) Each of the Medical Shareholders acknowledges and agrees
that:

                       (i) The Common Stock to be issued to the Medical
Shareholders (the "Exchanged Corporation Stock") is being issued to Medical
Shareholders without registration under applicable federal and state securities
laws in reliance upon certain exemptions from registration under such securities
laws;

                       (ii) He has had the opportunity to ask questions of and
receive answers from the Corporation, Medical and their respective executive
officers concerning their businesses and the Exchanged Corporation Stock and all
such inquiries have been completed to his satisfaction;

                       (iii) Each certificate representing shares of the
Exchanged Corporation Stock will bear a legend restricting its transfer, sale,
conveyance or hypothecation, unless such Exchanged Corporation Stock is either
registered under applicable securities laws or an exemption from such
registration is applicable, and provided that if an exemption from registration
is claimed, the Corporation may require an opinion of legal counsel that, as a
result of such exemption, registration under the securities laws is not required
to transfer, sell, convey or hypothecate such Exchanged Corporation Stock;

                       (iv) He shall not transfer any Exchanged Corporation
Stock except in compliance with all applicable securities laws;

                                       2
<PAGE>

                       (v) He has a pre-existing personal or business
relationship with Medical or its officers, directors, agents or controlling
persons, and has relied, if at all, on the advice of such persons in electing to
participate in the transaction herein contemplated and not on any
representations of the Corporation other than those expressly set forth herein,
or by reason of his business or financial experience could be reasonably assumed
to have the capacity to protect his own interest in connection with the
transaction;

                       (vi) He is acquiring the Exchanged Corporation Stock for
his own account, for investment purposes only and not with a view to the sale or
distribution thereof;

                       (vii) He has not received any general solicitation or
general advertising regarding the acquisition of the Exchanged Corporation
Stock; and

                       (viii) He is capable of evaluating the merits and risks
of an investment in the Common Stock because he is a sophisticated investor by
virtue of his prior investments and has experience in investments similar in
nature to the Common Stock, including investments in unlisted and unregistered
securities, and has knowledge and experience in financial and business matters
in general.

                   (b) The Corporation acknowledges and agrees that:

                       (i) The Medical capital stock is being transferred to the
Corporation without registration under applicable securities laws in reliance
upon certain exemptions from registration from such securities laws;

                       (ii) All certificates representing the Medical capital
stock bear legends restricting its transfer, sale, conveyance or hypothecation,
unless such Medical capital stock is either registered under the applicable
securities laws, or an exemption from such registration is applicable;

                       (iii) The Corporation shall not transfer any Medical
capital stock except in compliance with
all applicable securities laws; and

                       (iv) The Corporation is acquiring the Medical capital
stock for its own account for investment purposes only and not with a view to
the sale or distribution thereof.

         1.6 Closing. Consummation of the contemplated transaction shall take
place on the date that all the conditions set forth herein are satisfied or
waived by the appropriate parties at the offices of Jeffrey G. Klein, P.A., 2600
North Military Trail, Suite 270 Boca Raton, FL 33431 or at another time or place
that is mutually agreeable to the parties hereto, or on such other date at such
other time as may be mutually agreed upon in writing by the parties hereto (the
"Closing").

                                       3
<PAGE>

                                   ARTICLE II
                THE CORPORATION'S REPRESENTATIONS AND WARRANTIES

The Corporation hereby makes the following representations and warranties to the
Medical Shareholders and Medical, each of which the Corporation represents to be
true and correct on the date hereof and (except as the Corporation may notify
Medical in writing prior to the Closing) shall be deemed made again as of the
Closing and represented by the Corporation to be true and correct at the time of
the Closing.

         2.1 Organization. The Corporation is a corporation duly organized,
validly existing and in good standing under the laws of the State of Florida and
is qualified or licensed as a foreign corporation in any other jurisdiction
where said licensing is required. The Corporation has the full power and
authority to conduct the business in which it will engage upon completion of the
transaction contemplated herein. Except as set forth in the Corporation's
filings with the Securities and Exchange Commission, the Corporation does not
have any subsidiary or equity interest in any entity. Accurate, current and
complete copies of the Articles of Incorporation and Bylaws of the Corporation
to be provided prior to Closing and attached as Schedule 2.1.

         2.2 Stock Ownership. The authorized capital stock of the Corporation
consists of twenty five million shares of Common Stock, of which 4,209,144 are
issued and outstanding (excluding the Exchanged Corporation Stock).
Notwithstanding the above, the Corporation shall adjust its capital structure
such that, at closing, it shall have no more than 24,000 shares of common stock
issued and outstanding after giving effect to a contemplated 100:1 reverse
split.

All the issued and outstanding shares of capital stock of the Corporation are
duly authorized, validly issued, fully paid and nonassessable. Upon the issuance
of the Exchanged Corporation Stock, the Common Stock included in the Exchanged
Corporation Stock shall, on a fully diluted basis, constitute approximately 5%
of all the issued and outstanding Common Stock. Upon tender of the Medical
capital stock to the Corporation in the manner contemplated in Section 1.1
hereof, legal and beneficial ownership of the Exchanged Corporation Stock shall
be transferred to and vested in the Medical Shareholders free and clear of all
encumbrances,except those required by Rule 144 of the Securities Act,and all the
Exchanged Corporation Stock shall be duly authorized, validly issued, fully paid
and nonassessable. There are no outstanding bonds, debentures, notes or other
indebtedness or other securities of the Corporation having the right to vote (or
convertible into, or exchangeable for, securities having the right to vote) on
any matters on which shareholders of the Corporation may vote. Except as set
forth above, there are no outstanding securities, options, warrants, calls,
rights, commitments, agreements, arrangements or undertakings of any kind to
which the Corporation is a party or by which it is bound obligating the
Corporation to issue, deliver or sell, or cause to be issued, delivered or sold,
additional shares of capital stock or other equity or voting securities of the
Corporation or obligating the Corporation to issue, grant, extend or enter into

                                       4
<PAGE>

any such security, option, warrant, call, right, commitment, agreement,
arrangement or undertaking. There are no outstanding contractual obligations,
commitments, understandings or arrangements of the Corporation to repurchase,
redeem or otherwise acquire or make any payment in respect of any shares of
capital stock of the Corporation.

         2.3       Authority and Approval of Agreement.
                   ------------------------------------

                   (a) The execution and delivery of this Agreement by the
Corporation and the performance of all the Corporation's obligations hereunder
have been duly authorized and approved by all requisite corporate action on the
part of the Corporation pursuant to applicable law. The Corporation has the
power and authority to execute and deliver this Agreement and to perform all its
obligations hereunder.

                   (b) This Agreement and any other documents, instruments and
agreements executed by the Corporation in connection herewith constitute the
valid and legally binding agreements of the Corporation, enforceable against the
Corporation in accordance with their terms, except that (i) enforceability may
be limited by applicable bankruptcy, insolvency, reorganization, moratorium or
similar laws of general application affecting the enforcement of the rights and
remedies of creditors; and (ii) the availability of equitable remedies may be
limited by equitable principles.

         2.4       No Violations.

         Neither the execution, delivery nor performance of this Agreement or
any other documents, instruments or agreements executed by the Corporation in
connection herewith, nor the consummation of the transactions contemplated
hereby: (i) constitutes a violation of or default under (either immediately,
upon notice or upon lapse of time) the Articles of Incorporation or Bylaws of
the Corporation, any provision of any contract to which the Corporation may be
bound, any judgment or any law; or (ii) will or could result in the creation or
imposition of any encumbrance upon, or give to any third person any interest in
or right to, the Exchanged Corporation Stock or any other capital stock of the
Corporation; or (iii) will or could result in the loss or adverse modification
of, or the imposition of any fine or penalty with respect to, any license,
permit or franchise granted or issued to, or otherwise held by or for the use
of, the Corporation.

         2.5       Financial Statements. Schedule 2.5 will set forth the audited
financial statements of the Corporation ("Financial Statements"), including
balance sheets, statements of operations, statements of changes in shareholders'
equity and statements of cash flows for the fiscal year ended December 31, 2004
and the quarter ended June 30, 2005, the balance sheet as of June 30, 2005 being
hereinafter referred to as the "Balance Sheet". The Financial Statements and
Balance Sheet are true, correct and complete, were prepared in accordance with
generally accepted accounting principles consistently applied throughout the
periods indicated, and accurately

                                       5
<PAGE>

reflect the Corporation's financial condition and the results of the
Corporation's operations for the periods and as of the dates which they purport
to cover.

         2.6       Conduct Since Date of Balance Sheet. Except as disclosed in
Schedule 2.6 hereto or as otherwise set forth herein none of the following has
occurred since the date of the Balance Sheet:

                  (a) Any material adverse change in the financial condition,
obligations, capitalization, business, prospects or operations of the
Corporation, nor are there any circumstances known to the Corporation which
might result in such a material adverse change or such an effect;

                  (b) Any increase of indebtedness of the Corporation other than
in the ordinary course of business;

                  (c) Any settlement or other resolution of any dispute or
proceeding other than in the ordinary course of business;

                  (d) Any cancellation by the Corporation, without payment in
full, of any obligation to the Corporation of any shareholder, director, officer
or employee of the Corporation (or any member of their respective families), or
any entity in which any shareholder, director or officer of the Corporation (or
any member of their respective families) has any direct or indirect interests;

                  (e) Any obligation incurred by the Corporation other than in
the ordinary course of business;

                  (f) Any payment, discharge or satisfaction of any obligation
or judgment, other than in the ordinary course of business; or

                  (g) Any agreement obligating the Corporation to do or take any
of the actions referred to in this Section 2.7 outside the ordinary course of
business.

         2.7       Contracts. Schedule 2.7 will set forth an accurate, current
and complete list and description of each material contract and agreement,
whether written or oral ("Contract"), (other than this Agreement) to which the
Corporation is a party or by which the Corporation or any of its assets are
bound. An accurate, current and complete copy of each Contract described on
Schedule 2.7 hereto has been made available to Medical for inspection and
copying.

         2.8       Offers. There are no outstanding offers, bids, proposals or
quotations made by the Corporation which, if accepted, would create a Contract
with the Corporation.

         2.9       Officers, Directors, Agents, etc. Set forth on Schedule 2.9
annexed hereto is a complete list of all officers (with office held), directors,
contractors and agents of the Corporation, and the compensation and all vacation
and other benefits they are entitled to receive from the Corporation.

                                       6
<PAGE>

         2.10      Labor Matters. The Corporation is not and has never been
a party to: (i) any profit sharing, pension, retirement, deferred compensation,
bonus, stock option, stock purchase, retainer, consulting, health, welfare or
incentive plan or agreement or other employee benefit plan, whether legally
binding or not; or (ii) any plan providing for "fringe benefits" to its
employees, including, but not limited to, vacation, disability, sick leave,
medical, hospitalization and life insurance and other insurance plans, or
related benefits; or (iii) any employment agreement other than with Byron Webb.
No former employee of the Corporation has any claim against the Corporation
(whether under federal or state law, any employment agreement or otherwise) on
account of or for: (i) overtime pay; (ii) wages or salary for any period; (iii)
vacation, time-off or pay in lieu of vacation or time-off; or (iv) any violation
of any statute, ordinance or regulation relating to minimum wages or maximum
hours of work. No person or party (including, but not limited to, governmental
agencies of any kind) has any claim or basis for any action or proceeding
against the Corporation arising out of any statute, ordinance or regulation
relating to discrimination in employment or to employment practices or
occupational safety and health standards.

         2.11      Environmental Matters. Except as set forth on Schedule 2.11,
the Corporation has not generated any hazardous wastes or engaged in activities
which are or could be interpreted to be potential violations of laws or judicial
decrees in any manner regulating the generation or disposal of hazardous waste.
There are no on-site or off-site locations where the Corporation has stored,
disposed or arranged for the disposal of chemicals, pollutants, contaminants,
wastes, toxic substances, petroleum or petroleum products; there are no
underground storage tanks located on property owned or leased by the
Corporation, and no polychlorinated biphenyls are used or stored at any property
owned or leased by the Corporation.

         2.12      Books and Records. The Corporation's books and records are
and have been properly prepared and maintained in form and substance adequate
for preparing audited financial statements in accordance with generally accepted
accounting principles, and fairly and accurately reflect all of the
Corporation's assets, obligations and accruals, and all transactions (normally
reflected in books and records in accordance with generally accepted accounting
principles) to which the Corporation is or was a party or by which the
Corporation or any of its assets are or were affected.

         2.13      Taxes. Except as otherwise disclosed in this Agreement, or
any applicable SEC filings, all taxes due, owing and payable by the Corporation
have been fully paid. The amounts set up as provision for taxes on the Balance
Sheet are sufficient for the payment of all accrued and unpaid taxes of the
Corporation, whether or not disputed. The amount set up as provision for taxes
on the Corporation's books and records for the current fiscal year through the
Closing shall be sufficient for the payment of all accrued and unpaid taxes of
the Corporation, whether or not disputed, for such period. No claim for any tax
due from or assessed against the Corporation is being contested by the

                                       7
<PAGE>

Corporation. None of the Corporation's tax returns or reports has been audited
by the Internal Revenue Service or any state or local tax authority, and the
Corporation has not received any notice of deficiency or other adjustment from
the Internal Revenue Service or any state or local tax authority. There are no
agreements, waivers or other arrangements providing an extension of time with
respect to the assessment of any tax against the Corporation, nor are there any
tax proceedings now pending or threatened against the Corporation. No state of
facts exists or has existed, nor has any event occurred, which would constitute
grounds for the assessment of any further tax against the Corporation.

         2.14      Litigation. The Corporation is not a party to, the subject
of, or threatened with any litigation nor, to the best of the Corporation's
knowledge, is there any basis for any litigation. The Corporation is not
contemplating the institution of any litigation.

         2.15      Other Liabilities. No claim of breach of contract, tort,
product liability or other claim, contingent or otherwise, has been asserted or
threatened against the Corporation nor, to the best of the Corporation's
knowledge, is capable of being asserted by any employee, creditor, claimant or
other person against the Corporation. No state of facts exists or has existed,
nor has any event occurred, which could give rise to the assertion of any such
claim by any person.

         2.16      Consents. Subject to the submission of this matter to a vote
of the Corpoartion's shareholders, the execution, delivery and performance by
the Corporation of this Agreement and the consummation by the Corporation of the
transactions contemplated hereby do not require any consent that has not been
received prior to the date hereof.

         2.17      Judgments. There is no outstanding judgment against the
Corporation. There is no health or safety problem involving or affecting the
Corporation. There are no open workers compensation claims against the
Corporation, or any other obligation, fact or circumstance which would give rise
to any right of indemnification on the part of any current or former
shareholder, director, officer, employee or agent of the Corporation, or any
heir or personal representative thereof, against the Corporation or any
successor to the businesses of the Corporation.

         2.18      Improper Payments. Neither the Corporation, nor any of its
current or former shareholders, directors, officers or employees or agents, nor
any person acting on behalf of the Corporation, has, directly or indirectly,
made any bribe, kickback or other payment of a similar or comparable nature,
whether lawful or not, to any person, public or private, regardless of form,
whether in money, property or services, to obtain favorable treatment for
business secured or special concessions already obtained. No funds or assets of
the Corporation were donated, lent or made available directly or indirectly for
the benefit of, or for the purpose of supporting or opposing, any government or
subdivision thereof, political party, candidate or committee, either domestic or
foreign. The Corporation has not maintained and does not maintain a bank
account, or any other account of any kind, whether domestic or foreign, which

                                       8
<PAGE>

account was not or is not reflected in the Corporation's books and records, or
which account was not listed, titled or identified in the name of the
Corporation.

         2.19      Full Disclosure. All the representations and warranties made
by the Corporation herein or in any Schedule, and all of the statements,
documents or other information pertaining to the transaction contemplated herein
made or given by the Corporation, its agents or representatives, are complete
and accurate, and do not omit any information required to make the statements
and information provided, in light of the transaction contemplated herein,
non-misleading, accurate and meaningful.

                                   ARTICLE III
                    MEDICAL'S REPRESENTATIONS AND WARRANTIES

Medical hereby makes the following representations and warranties to the
Corporation, each of which Medical represents to be true and correct on the date
hereof and (except as Medical may notify the Corporation in writing prior to the
Closing) shall be deemed made again as of the Closing and represented by Medical
to be true and correct at the time of the Closing.

         3.1       Organization. Medical is a corporation duly organized,
validly existing and in good standing under the laws of the State of Florida and
is not required to be qualified or licensed as a foreign corporation in any
other jurisdiction. Medical has the full power and authority to own all its
assets and to conduct its business as and where its business is presently
conducted. Accurate, current and complete copies of the Articles of
Incorporation and Bylaws of Medical are to be attached hereto as Schedule 3.1.
Medical has no subsidiaries or equity interest in any entity.

         3.2       Stock Ownership. The authorized capital stock of Medical
consists of 25 million shares of common stock, $.001 par value of which
8,109,414 are currently issued and outstanding. All the issued and outstanding
capital stock of Medical is duly authorized, validly issued, fully paid and
nonassessable. There are no outstanding bonds, debentures, notes or other
indebtedness or other securities of Medical having the right to vote (or
convertible into, or exchangeable for, securities having the right to vote) on
any matters on which shareholders of Medical may vote. Except as set forth
above, there are no outstanding securities, options, warrants, calls, rights,
commitments, agreements, arrangements or undertakings of any kind to which
Medical is a party or by which it is bound obligating Medical to issue, deliver
or sell, or cause to be issued, delivered or sold, additional shares of capital
stock or other equity or voting securities of Medical or obligating Medical to
issue, grant, extend or enter into any such security, option, warrant, call,
right, commitment, agreement, arrangement or undertaking. There are no
outstanding contractual obligations, commitments, understandings or arrangements
of Medical to repurchase, redeem or otherwise acquire or make any payment in
respect of any shares of capital stock of Medical. Notwithstanding the
foregoing, if prior to closing, Medical Connections shall issue additional
shares of common stock, Medical Connections shall so advise the Corporation.
However, the total number of shares of the Exchanged Corporation Stock to be

                                       9
<PAGE>

delivered to the Medical shareholders shall not be adjusted as a result of any
increase or decrease in the issued and outstanding common stock of Medical
Connections.

         3.3       Authority and Approval of Agreement.

                  (a) The execution and delivery of this Agreement by Medical
and the performance of all Medical's obligations hereunder have been duly
authorized and approved by all requisite corporate action on the part of Medical
pursuant to applicable law. Medical has the power and authority to execute and
deliver this Agreement and to perform all its obligations hereunder.

                  (b) This Agreement and each of the other documents,
instruments and agreements executed by Medical in connection herewith constitute
the valid and legally binding agreements of Medical, enforceable against Medical
in accordance with their terms, except that: (i) enforceability may be limited
by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws
of general application affecting the enforcement of the rights and remedies of
creditors; and (ii) the availability of equitable remedies may be limited by
equitable principles.

         3.4       No Violations. Neither the execution, delivery nor
performance of this Agreement or any other documents, instruments or agreements
executed by Medical in connection herewith, nor the consummation of the
transactions contemplated hereby: (i) constitutes a violation of or default
under (either immediately, upon notice or upon lapse of time) the Articles of
Incorporation or Bylaws of Medical, any provision of any Contract to which
Medical or its assets may be bound, any judgment to which Medical is bound or
any law applicable to Medical; or (ii) result in the creation or imposition of
any encumbrance upon, or give to any third person any interest in or right to,
any other capital stock of Medical or any of the assets of Medical; or (iii)
result in the loss or adverse modification of, or the imposition of any fine or
penalty with respect to, any license, permit or franchise granted or issued to,
or otherwise held by or for the use of, Medical.

         3.5       Consents. Subject only to the consents of the Medical
Connections shareholders, the execution, delivery and performance by Medical of
this Agreement and the consummation by Medical of the transactions contemplated
hereby do not require any consent that has not been received prior to the date
hereof.

         3.6       Medical Financial Statements. Schedule 3.6 sets forth the
financial statements of Medical ("Medical Financial Statements"), including the
audited balance sheet, statements of operations, statements of changes in
stockholders' equity and statements of cash flows for the period ended December
31, 2004, and the fiscal quarter ending June 30, 2005 (the balance sheet as of
September 30, 2005 being hereinafter referred to as the "Medical Balance
Sheet"). The Medical Financial Statements are true, correct and complete, were
prepared in accordance with generally accepted accounting principles
consistently applied throughout the periods indicated, and accurately reflect
Medical's financial condition and the results of Medical's operations for the
periods and as the dates which they purport to cover.

                                       10
<PAGE>

         3.7       Conduct Since Date of Medical Balance Sheet. Except as
disclosed in Schedule 3.7 hereto or as otherwise set forth herein, none of the
following have occurred since the date of the Medical Balance Sheet:

                  (a) Any material adverse change in the financial condition,
obligations, capitalization, business, prospects or operations of Medical, nor
are there any circumstances known to Medical which might result in such a
material adverse change or such an effect;

                  (b) Any increase of indebtedness of Medical other than in the
ordinary course of business;

                  (c) Any settlement or other resolution of any dispute or
proceeding including Medical other than in the ordinary course of business;

                  (d) Any cancellation by Medical, without payment in full, of
any obligation to Medical of any shareholder, partner, director, officer or
employee of Medical (or any member of their respective families), or any person
in which any shareholder, partner, director or officer of Medical (or any member
of their respective families) has any direct or indirect interest;

                  (e) Any obligation incurred by Medical other than in the
ordinary course of business;

                  (f) Any payment, discharge or satisfaction of any obligation
or judgment of or against Medical, other than in the ordinary course of
business; or

                  (g) Any Contract obligating Medical to do or take any of the
actions referred to in this Section 3.7 outside the ordinary course of business.

         3.8       Contracts. Schedule 3.8 will set forth an accurate, current
and complete list and description of each material Contract (other than this
Agreement) to which Medical is a party or by which Medical or any of its assets
are bound. An accurate, current and complete copy of each material Contract
described in Schedule 3.8 hereto has been furnished to the Corporation.

         3.9       Offers. There are no outstanding offers, bids, proposals or
quotations made by Medical which, if accepted, would create a Contract with
Medical.

         3.10      Officers, Directors, Agents, etc. Set forth on Schedule 3.10
to be annexed hereto is a complete list of all officers (with office held),
directors, contractors and agents of Medical, and the compensation and all
vacation and other benefits they are entitled to receive from Medical.

                                       11
<PAGE>

         3.11      Labor Matters. Medical is not and has never been a party to:
(i) any profit sharing, pension, retirement, deferred compensation, bonus, stock
option, stock purchase, retainer, consulting, health, welfare or incentive plan
or agreement or other employee benefit plan, whether legally binding or not; or
(ii) any plan providing for "fringe benefits" to its employees, including, but
not limited to, vacation, disability, sick leave, medical, hospitalization and
life insurance and other insurance plans, or related benefits; or (iii) any
employment agreement. No former employee of Medical has any claim against
Medical (whether under federal or state law, any employment agreement or
otherwise) on account of or for: (i) overtime pay; (ii) wages or salary for any
period; (iii) vacation, time-off or pay in lieu of vacation or time-off; or (iv)
any violation of any statute, ordinance or regulation relating to minimum wages
or maximum hours of work. No person or party (including, but not limited to,
governmental agencies of any kind) has any claim or basis for any action or
proceeding against Medical arising out of any statute, ordinance or regulation
relating to discrimination in employment or to employment practices or
occupational safety and health standards.

         3.12      Environmental Matters. Except as set forth in Schedule 3.12
Medical has not generated any hazardous wastes or engaged in activities which
are or could be interpreted to be potential violations of laws or judicial
decrees in any manner regulating the generation or disposal of hazardous waste.
There are no on-site or off-site locations where Medical has stored, disposed or
arranged for the disposal of chemicals, pollutants, contaminants, wastes, toxic
substances, petroleum or petroleum products; there are no underground storage
tanks located on property owned or leased by Medical.

         3.13      Books and Records. Medical's books and records are and have
been properly prepared and maintained in form and substance adequate for
preparing audited financial statements in accordance with generally accepted
accounting principles, and fairly and accurately reflect all of Medical's
assets, obligations and accruals, and all transactions (normally reflected in
books and records in accordance with generally accepted accounting principles)
to which Medical is or was a party or by which Medical or any of its assets are
or were affected.

         3.14      Taxes. Except as otherwise disclosed in this Agreement, all
taxes due, owing and payable by Medical have been fully paid. The amounts set up
as provision for taxes on the Medical Balance Sheet are sufficient for the
payment of all accrued and unpaid taxes of Medical, whether or not disputed. The
amount set up as provision for taxes on Medical's books and records for the
current fiscal year through the Closing shall be sufficient for the payment of
all accrued and unpaid taxes of Medical, whether or not disputed, for such
period. No claim for any tax due from or assessed against Medical is being
contested by Medical. None of Medical's tax returns or reports has been audited
by the Internal Revenue Service or any state or local tax authority, and Medical
has not received any notice of deficiency or other adjustment from the Internal
Revenue Service or any state or local tax authority. There are no agreements,
waivers or other arrangements providing an extension of time with respect to the
assessment of any tax against Medical, nor are there any tax proceedings now
pending or threatened against Medical. No state of facts exists or has existed,
nor has any event occurred, which would constitute grounds for the assessment of
any further tax against Medical.

                                       12
<PAGE>

         3.15      Litigation. Except as set forth in Schedule 3.15, Medical is
not a party to, the subject of, or threatened with any litigation nor, to the
best of Medical's knowledge, is there any basis for any litigation. Medical is
not contemplating the institution of any litigation.

         3.16      Other Liabilities. No claim of breach of contract, tort,
product liability or other claim (whether arising from Medical's business
operations or otherwise), contingent or otherwise, has been asserted or
threatened against Medical nor, to the best of Medical's knowledge, is capable
of being asserted by any employee, creditor, claimant or other person against
Medical. No state of facts exists or has existed, nor has any event occurred,
which could give rise to the assertion of any such claim by any person.

         3.17      Consents. The execution, delivery and performance by Medical
of this Agreement and the consummation by Medical of the transactions
contemplated hereby do not require any consent that has not been received prior
to the date hereof.

         3.18      Judgments. There is no outstanding judgment against Medical.
There is no health or safety problem involving or affecting Medical. There are
no open workers compensation claims against Medical, or any other obligation,
fact or circumstance which would give rise to any right of indemnification on
the part of any current or former shareholder, partner, director, officer,
employee or agent of Medical, or any heir or personal representative thereof,
against Medical or any successor to the business of Medical.

         3.19      Compliance with Laws.  Medical and its business are in full
compliance with all laws.

         3.20      Improper Payments. Neither Medical, nor any of its current or
former shareholders, partners, directors, officers or employees or agents, nor
any person acting on behalf of Medical, has, directly or indirectly, made any
bribe, kickback or other payment of a similar or comparable nature, whether
lawful or not, to any person, public or private, regardless of form, whether in
money, property or services, to obtain favorable treatment for business secured
or special concessions already obtained. No funds or assets of Medical were
donated, lent or made available directly or indirectly for the benefit of, or
for the purpose of supporting or opposing, any government or subdivision
thereof, political party, candidate or committee, either domestic or foreign.
Medical has not maintained and does not maintain a bank account, or any other
account of any kind, whether domestic or foreign, which account was not or is
not reflected in the Medical corporate books and records, or which account was
not listed, titled or identified in the name of Medical.

                                       13
<PAGE>

         3.21      Full Disclosure. All the representations and warranties made
by Medical herein or in any Schedule hereto, and all of the statements,
documents or other information pertaining to the transaction contemplated herein
made or given by Medical, its agents or representatives are complete and
accurate, and do not omit any information required to make the statements and
information provided, in light of the transaction contemplated herein,
non-misleading, accurate and meaningful.

                                   ARTICLE IV
                     MEDICAL SHAREHOLDERS' REPRESENTATIONS,
                            WARRANTIES AND AGREEMENTS

Each Medical Shareholder hereby makes the following representations and
warranties to the Corporation, each of which such Medical Shareholder represents
to be true and correct on the date hereof and (except as such Medical
Shareholder may notify the Corporation in writing prior to the Closing) shall be
deemed made again as of the Closing and represented by such Medical Shareholder
to be true and correct at the time of the Closing.

         4.1       Title to Stock. He is the sole owner, legally and
beneficially, of the Medical capital stock set forth on Schedule 1.1 hereto
opposite his name, the consideration payable by him therefore has been paid and
such stock is fully paid and nonassessable and free and clear of all
encumbrances of every kind. He has full legal right, power and authority to
enter into this Agreement and to sell, assign and transfer such stock to the
Corporation. The delivery to the Corporation of such stock pursuant to the
provisions of this Agreement will transfer to the Corporation valid title
thereto, free and clear of all encumbrances of every kind except any created by
the Corporation. The Medical capital stock represents his entire interest in
Medical. He has no other rights, claims or interest to, against or in Medical,
or its officers and directors.

         4.2       Enforceability. This Agreement and each of the other
documents, instruments and agreements executed by him in connection herewith
constitute the valid and legally binding agreements of him, enforceable against
him in accordance with their terms, except that: (i) enforceability may be
limited by applicable bankruptcy, insolvency, reorganization, moratorium or
similar laws of general application affecting the enforcement of the rights and
remedies of creditors; and (ii) the availability of equitable remedies may be
limited by equitable principles.

         4.3       Brokerage Fees. There is no person acting on behalf of him
who is entitled to or has any claim for any brokerage or finder's fee or
commission in connection with the execution of this Agreement or the
consummation of the transactions contemplated hereby.

                                       14
<PAGE>

                                    ARTICLE V
                         INTERPRETATION AND SURVIVAL OF
                         REPRESENTATIONS AND WARRANTIES

         5.1       Interpretation. Each warranty and representation made by a
party in this Agreement or pursuant hereto is independent of all other
warranties and representations made by the same party in this Agreement or
pursuant hereto (whether or not covering identical, related or similar matters)
and must be independently and separately satisfied. Exceptions or qualifications
to any such warranty or representation shall not be construed as exceptions or
qualifications to any other warranty or representation.

         5.2       Survival. All representations and warranties made in this
Agreement or pursuant hereto shall survive the date hereof, the Closing, the
consummation of the transaction contemplated hereby and any investigation.

                                   ARTICLE VI
                          OBLIGATIONS PRIOR TO CLOSING

         6.1       Conduct of the Corporation and Medical Pending Closing.
During the period from the date hereof until the Closing Date, except with the
express prior written consent of the other party, the Corporation and Medical
hereby covenant and agree that:

                  (a) each shall maintain its existence in good standing in the
state of its incorporation and each other jurisdiction where it is required to
be licensed or qualified as a foreign corporation, and shall not alter or amend
its Articles of Incorporation or Bylaws;

                  (b) each shall duly and timely file all returns and reports
required by any law to be filed by it, shall promptly pay when due all taxes
assessed against it or any of its assets, and shall conform to and fully comply
with all the laws pertaining to its assets or the conduct of its business; and

                  (c) each shall not take any action, or enter into any
agreement that would cause a breach of any of the representations and warranties
made herein by the Corporation or Medical, as applicable.

                                   ARTICLE VII

                    CONDITIONS PRECEDENT TO MEDICAL'S AND THE
                        MEDICAL SHAREHOLDERS' OBLIGATIONS

Notwithstanding the execution and delivery of this Agreement or the performance
of any part hereof, Medical's and each of the Medical Shareholders' respective
obligations to consummate the transaction contemplated by this Agreement shall
be subject to the satisfaction of each of the conditions set forth in this
Article VII, except to the extent that such satisfaction is waived in writing by
Medical and a majority in interest of the Medical Shareholders.

                                       15
<PAGE>

         7.1       Representations and Warranties of the Corporation. All
representations and warranties made by the Corporation in this Agreement and the
Schedules hereto shall be true and correct in all respects on the date hereof,
and shall be true and correct in all respects at the time of the Closing as
though such representations were again made, without exception or deviation, at
the time of the Closing.

         7.2       Performance of this Agreement. The Corporation shall have
duly performed or complied with all the obligations under this Agreement to be
performed or complied with by the Corporation on or prior to the Closing.

         7.3       Absence of Litigation. No litigation shall have been
instituted on or before the time of the Closing by any person, the result of
which did or could prevent or make illegal the consummation of the transaction
contemplated by this Agreement, or which had or could have a material adverse
effect on the business of the Corporation.

         7.4       Deliveries at Closing. At or prior to Closing, in addition to
all other deliveries to be made by the Corporation, the Corporation shall
deliver or cause to be delivered to Medical and the Medical Shareholders a
certificate signed by Byron Webb, President of the Corporation, dated the
Closing, certifying that: (a) all of the terms and conditions of this Agreement
to be satisfied or performed by the Corporation on or before the time of the
Closing have been satisfied or performed; (b) no litigation has been instituted
or, to the best knowledge of Mr. Webb, there is no threatened on or before the
time of the Closing by any person (other than Medical), the result of which did
or could prevent or make illegal the consummation of the transaction
contemplated by this Agreement, or which had or could have a material adverse
effect on the business of the Corporation; and (c) there has not been any
material adverse change in or affecting the Corporation between the date of this
Agreement and the time of the Closing.

         7.5       Schedules. The Corporation shall have provided to Medical and
its Shareholders all referenced schedules.

                                       16
<PAGE>

                                  ARTICLE VIII

                           CONDITIONS PRECEDENT TO THE
                            CORPORATION'S OBLIGATIONS

Notwithstanding the execution and delivery of this Agreement or the performance
of any part hereof, the Corporation's obligations to consummate the transaction
contemplated by this Agreement shall be subject to the satisfaction of each of
the conditions set forth in this Article VIII, except to the extent that such
satisfaction is waived by the Corporation in writing.

         8.1       Representations and Warranties of Medical and the Medical
Shareholders. All representations and warranties made by Medical and the Medical
Shareholders contained in this Agreement and the Schedules hereto shall be true
and correct in all respects on the date hereof, and shall be true and correct in
all respects at the time of the Closing as though such representations were
again made, without exception or deviation, at the time of the Closing.

         8.2       Performance of this Agreement. The owners of 100% of the
issued and outstanding shares of common stock of Medical shall have executed
this Agreement. Medical and the Medical Shareholders shall have duly performed
or complied with all of the covenants and obligations under this Agreement to be
performed or complied with by them on or prior to the Closing.

         8.3       Absence of Litigation. Except as otherwise disclosed in this
agreement, no litigation has been instituted on or before the time of the
Closing by any person, the result of which did or could prevent or make illegal
the consummation of the transaction contemplated by this Agreement.

         8.4       Deliveries at Closing. At Closing, in addition to all other
deliveries to be made to the Corporation hereunder, the Corporation shall
receive a certificate signed by Joseph Azzata, the CEO of Medical, dated as of
the Closing, certifying that: (a) all of the terms and conditions of this
Agreement to be satisfied or performed by Medical on or before the time of the
Closing have been satisfied or performed; (b) except as set forth in this
Agreement, there is no other litigation has been instituted or, to the best of
Mr. Azzata's knowledge, threatened on or before the time of the Closing by any
person (other than the Corporation), the result of which did or could prevent or
make illegal the consummation of the transaction contemplated by this Agreement,
or which had or could have a material adverse effect on the business of Medical;
and (c) there has not been any material adverse change in or affecting Medical
between the date of this Agreement and the time of the Closing.

         8.5       Schedules.   Medical shall have provided to the Corporation
all referenced schedules.

                                       17
<PAGE>

                                   ARTICLE IX
                             OBLIGATIONS AT CLOSING

         9.1       Obligations of the Corporation and Webb to Medical and the
Medical Shareholders at Closing. The Corporation hereby covenants and agrees to
deliver or cause to be delivered to Medical and Medical Shareholders at the
Closing the following:

                  (a) Duly issued certificates (legended as provided in Section
1.5(a)(iii) hereof) representing all the Exchanged Corporation Stock, together
with any documentary stamps required in connection with such transfer and such
other appropriate documents and instruments of transfer as Medical may
reasonably request.

                  (b) An Active Status Certificate for the Corporation, dated no
earlier than ten (10) days before the Closing, from the State of Florida.

                  (c) A copy of the resolutions adopted by the Board of
Directors of the Corporation, certified by its corporate secretary, which
resolutions authorize it to execute, deliver and perform this Agreement and
consummate the transactions contemplated hereby.

                  (d) Such corporate resolutions, resignations and other
documents as shall be required to remove all officers and directors of the
Corporation and to replace them with the following officers and directors:

                  Joseph Azzata
                  Anthony J. Nicolosi

                   (e) Webb shall cancel all of his share  ownership in the
Corporation  as set forth in paragraph 1.2 above

         9.2       Medical's Obligations to the Corporation and Webb at Closing.
Medical agrees to deliver or cause to be delivered to the Corporation (paragraph
(a)-(c) only) and Webb (paragraph (d) only) at the Closing the following:

                  (a) A Good Standing Certificate for Medical dated no earlier
than ten (10) days before the Closing, from the State of Florida.

                  (b) A copy of the resolutions adopted by the Board of
Directors of Medical, certified by its corporate secretary, which resolutions
authorize it to execute, deliver and perform this Agreement and consummate the
transactions contemplated hereby.

                  (c) All outstanding Medical capital stock certificates to be
exchanged for shares of Exchanged Corporation Stock free and clear of all
encumbrances, together with all certificates evidencing the same and stock
powers therefore, in a form acceptable to the Corporation, duly executed in
blank.

                  (d)      $200,000 to Webb as set forth in paragraph 1.2 above

         9.3       Medical Shareholders' Obligations to the Corporation at
Closing. Each Medical Shareholder hereby covenants and agrees to deliver to the
Corporation at the Closing the following:

                  (a) If not previously delivered to Medical for such purposes,
all his Medical capital stock certificates, free and clear of all encumbrances,
together with all certificates evidencing same and stock powers therefore, in a
form acceptable to the Corporation, duly executed in blank.

                   (b) Such other documents and instruments as counsel to the
Corporation may reasonably request.

                                       18
<PAGE>

                                    ARTICLE X

                                   TERMINATION

         10.1 Termination on Default. If, prior to the Closing, a party hereto
shall materially breach or default in the full and timely performance and
satisfaction of any of its representations and warranties or obligations under
this Agreement, and such breach or default is not cured on or before the fifth
(5th) day after the date notice is given by the non-defaulting party to the
defaulting party specifying the nature of such breach or default (or at or
before the time of the Closing if sooner), then the non-defaulting party may
terminate this Agreement immediately upon notice to the defaulting party;
provided, however, that no Medical Shareholder may terminate this Agreement.

         10.2 Termination at Closing. If any of the conditions set forth in
Article VII hereof are not satisfied at or before the time of the Closing, then
Medical may terminate this Agreement by notifying the Corporation at the
Closing. If any of the conditions set forth in Article VIII hereof are not
satisfied at or before the time of the Closing, then the Corporation may
terminate this Agreement by notifying Medical and all the Medical Shareholders
at the Closing.

                                   ARTICLE XI

                                OTHER AGREEMENTS

         11.1      Name Change. Contemporaneously with the consummation of this
transaction, the Corporation shall change its name to Medical Connections, Inc.

                                   ARTICLE XII

                                  MISCELLANEOUS

         12.1 Notices. All notices, requests, demands and other communications
hereunder shall be deemed to have been duly given if the same shall be in
writing and shall be delivered personally or sent by registered or certified
mail, postage prepaid, and addressed as set forth below:

                                             If to the Corporation:
                                             155 Wilson Lake
                                             Road, Mooresville, NC 28117
                                             ATTN: BYRON WEBB

                  If to Medical or the
                                             Medical Shareholders:
                                             2300 Glades Road Suite 202 E
                                             Boca Raton, FL 33431
                                             Attn: Joseph Azzata

         12.2      Entire Agreement. This Agreement, including the Schedules
attached hereto and the documents delivered pursuant hereto, sets forth all the
promises, covenants, agreements, conditions and understandings among the parties
hereto with respect to the subject matter hereof, and supersedes all prior and
contemporaneous agreements, understandings, inducements or conditions, expressed
or implied, oral or written, except as herein contained. No changes of or
modifications or additions to this Agreement shall be valid unless same shall be
in writing and signed by the parties hereto.

         12.3      Binding Effect; Assignment. This Agreement shall be binding
upon the parties hereto, their beneficiaries, heirs and administrators. No party
may assign or transfer its interests herein, or delegate its duties hereunder,
without the written consent of the other parties.

         12.4      Amendment. The parties hereby irrevocably agree that no
attempted amendment, modification or change (collectively, "Amendment") of this
Agreement shall be valid and effective, unless the parties shall unanimously
agree in writing to such Amendment.

         12.5      No Waiver. No waiver of any provision of this Agreement shall
be effective unless it is in writing and signed by the party against whom it is
asserted, and any such written waiver shall only be applicable to the specific
instance to which it relates and shall not be deemed to be a continuing or
future waiver.

         12.6      Gender and Use of Singular and Plural. All pronouns shall be
deemed to refer to the masculine, feminine, neuter, singular or plural, as the
identity of the party or parties or their personal representatives, successors
and assigns may require.

         12.7      Counterparts. This Agreement and any Amendments may be
executed in one or more counterparts, each of which shall be deemed an original
and all of which together shall constitute one and the same instrument.

         12.8      Headings. The article and section headings contained in this
Agreement are inserted for convenience only and shall not affect in any way the
meaning or interpretation of the Agreement.

                                       19
<PAGE>

         12.9      Governing Law. This Agreement shall be construed in
accordance with the laws of the State of Florida.

         12.10     Further Assurances. The parties hereto shall execute and
deliver such further instruments and do such further acts and things as may be
reasonably required to carry out the intent and purposes of this Agreement.

         12.11     Litigation. If any party hereto is required to engage in
litigation or arbitration against any other party hereto, either as plaintiff or
as defendant, in order to enforce or defend any of its or his rights under this
Agreement, and such litigation results in a final judgment in favor of such
party (the "Prevailing Party"), then the party or parties against whom said
final judgment is obtained shall reimburse the Prevailing Party for all direct,
indirect or incidental expenses incurred by the Prevailing Party in so enforcing
or defending its or his rights hereunder, including, but not limited to, all
attorneys' fees, paralegals' fees, court costs and other expenses incurred
throughout all negotiations, trials or appeals undertaken in order to enforce
the Prevailing Party's rights hereunder.

         12.12     Confidentiality. Except for discussions of the transactions
contemplated by this Agreement among the parties hereto and their respective
representatives and counsel participating in this transaction, and except as may
be required of the Corporation pursuant to federal securities laws, each party
hereto shall, unless all other parties hereto shall otherwise agree, keep
confidential and not, directly or indirectly, disclose to any person the
existence of this Agreement, the transaction contemplated by this Agreement or
any of the terms thereof, or the fact that the Corporation and Medical have
entered into discussions or negotiations for any purpose whatsoever, and each
party hereto shall use its good faith efforts to cause its employees, agents,
officers, directors and representatives to abide by the foregoing restrictions
on disclosure.

                                       20
<PAGE>

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed
as of the date and year set forth above.

                                       WEBB MORTGAGE DEPOT, INC.

                                       By: /s/Byron Webb
                                           -------------------------------------
                                           Name: Byron Webb
                                           Title: President

                                       MEDICAL CONNECTIONS, INC.

                                       By: /s/Joseph Azzata
                                           -------------------------------------
                                           Name: Joseph Azzata
                                           Title: CEO

                                           /s/ Byron Webb
                                           -------------------------------------
                                           Byron Webb, individually

                                           MEDICAL CONNECTIONS, INC.
                                           SHAREHOLDERS:

                                           -------------------------------------

                                           -------------------------------------

                                           -------------------------------------

                                       21EXHIBIT 10.6

         CONFIDENTIAL TREATMENT REQUESTED OF ITEMS MARKED [--OMITTED--]

                             DISTRIBUTION AGREEMENT

               THIS DISTRIBUTION AGREEMENT entered into as of the 30th day of
September, 2005 (the "Effective Date") by and between DEGUSSA WALL SYSTEMS,
INC., a Delaware corporation ("Degussa") and JUST-RITE SUPPLY, INC., a Florida
corporation ("Just-Rite"). Degussa and Just-Rite may hereinafter be referred to
individually as a "Party" or collectively as the "Parties."

                                R E C I T A L S:

         A. Degussa and an affiliate of Just-Rite Supply, Inc. entered into that
certain Asset Purchase Agreement as of July 25, 2005 ("Purchase Agreement"),
whereby Degussa purchased certain of the assets associated with the
manufacturing operations of Acrocrete, Inc. and the Acrocrete products produced
in Acrocrete's Kennesaw, Georgia manufacturing facility.

         B. Following the closing of the Purchase Agreement, Degussa will
manufacture those certain Acrocrete products under the trade name "Acrocrete" as
identified on Exhibit "A" hereto which were previously manufactured by
Acrocrete, Inc. immediately prior to such closing (the "Products").

         C. Degussa desires to appoint Just-Rite as its exclusive distributor of
the Products in the States of Alabama, Florida, Georgia, Louisiana and
Mississippi (the "Territory") and Just-Rite has agreed to serve as the exclusive
distributor of the Products in the Territory, subject to the terms and
conditions hereof.

         NOW, THEREFORE, in consideration of the mutual promises and covenants
contained herein and such other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties agree as follows:

         1. RECITATIONS. The above recitations are true and correct and are
incorporated herein by this reference.

         2. APPOINTMENT. Degussa hereby appoints Just-Rite as its exclusive
distributor of the Products in the Territory. Just-Rite shall have the exclusive
right to sell to, solicit and take orders from customers within the Territory
for the Products. Just-Rite accepts such appointment and agrees to act as
exclusive distributor within the Territory. In connection therewith, Just-Rite
agrees not to purchase products and supplies of other manufacturers for sale in
the Territory that perform the same purpose as the Products, so long as the
Products are available for purchase from Degussa. Such exclusivity shall not
impair Just-Rite's ability to sell products which are manufactured by its
affiliates.

<PAGE>

         3. RIGHT OF FIRST REFUSAL. During the term hereof, Degussa hereby
grants to Just-Rite a Right of First Refusal to serve as the exclusive
distributor in [----OMITTED----] ("New Territories"). Just-Rite shall notify
Degussa of the establishment of a new facility. Upon such notification, and upon
approval by Degussa based on the other conditions set forth in this Section 3,
Just-Rite shall become the exclusive distributor for Products for the New
Territories.

         4. JUST-RITE DUTIES. Just-Rite agrees to use it best efforts to
actively and diligently promote and sell the Products in the Territory.
Just-Rite shall purchase one hundred percent (100%) of its requirements of the
Products from Degussa. Just-Rite shall solicit and take orders from their
potential customers at prices to be established from time to time by Just-Rite
and on the terms and conditions specified by Just-Rite. Decisions regarding
customer credit and all matters relating to billing shall be made only by
Just-Rite.

         5. DEGUSSA DUTIES. Degussa shall use its best efforts to continuously
and timely manufacture Products during the Term (as hereinafter defined)
sufficient to meet the demands of Just-Rite. Degussa shall sell to Just-Rite the
Products upon the terms hereof and shall ship such Products to Just-Rite in a
timely and commercially reasonable manner; provided, however, that Just-Rite
shall be current under the payment terms set forth herein. Degussa agrees that
it will refer any inquiries of purchases of Products directly to Just-Rite as
its exclusive distributor within the Territory. Degussa will ship the Products
FOB Degussa's facility. Just-Rite may give to Degussa direction for direct
shipment from time to time to Just-Rite's customers. Upon receipt of such
directions, Degussa agrees to directly ship the Products in accordance therewith
and charge Just-Rite the cost of shipping. Degussa shall provide to Just-Rite
marketing materials, sales and product literature and general sales and
marketing support comparable to the materials, literature and support provided
by Degussa to distributors of its other product lines such as Finestone, Senergy
and Sonowall Stucco Systems (the "Other Product Lines").

         6. TRADEMARK. Degussa hereby grants to Just-Rite, a royalty free
license to use the trademark "Acrocrete" (the "Trademark") on and in connection
with the promotion and sale of Products. Such use shall at all times meet such
commercially reasonable requirements with respect to style, appearance and
quality as Degussa may establish from time to time to ensure that the standards
of all products and promotions using the Trademark shall be maintained.
Just-Rite expressly agrees that it shall not have any right, title or interest
in the Trademark, except as otherwise provided herein. Nothing in this Agreement
shall be construed to grant or assign to Just-Rite any additional right, title
or interest in said Trademark. Degussa makes no representation or warranty with
respect to the ownership of any rights relating to the Trademark.

         7. PRICE OF PRODUCTS. All sales of the Products by Degussa to Just-Rite
shall be made at the pricing as set forth on Exhibit B. Such pricing shall
remain unchanged for a period of [----OMITTED----] from the Effective Date.
After [----OMITTED----] of the Effective Date, Degussa shall have the right to
increase prices for the Products at a level commensurate with increases to
Degussa's Other Product Lines.;

                                       2

<PAGE>

         8. PAYMENT. Payment for Products purchased by Just-Rite shall be paid
[----OMITTED----]. All payments shall be paid to Degussa at the address
indicated in the Notices section indicated below or such other address that
Degussa shall provide to Just-Rite from time to time during the term of this
Agreement. In the event of termination of this Agreement all sums then unpaid
shall continue to be payable on the terms and conditions set forth herein.

         9. TITLE AND RISK OF LOSS. Title and risk of loss or damage to Products
shall pass from Degussa to Just-Rite upon delivery to the carrier at Degussa's
manufacturing facility.

         10. MINIMUM PURCHASE REQUIREMENTS. During the Term of this Agreement,
and so long as Degussa continues to manufacture Products in sufficient quantity,
Just-Rite shall purchase a minimum of [----OMITTED----] ($[----OMITTED----]) of
Products and any other products sold or to be sold by Degussa during the Term,
including Acrodry ("Degussa Products") from Degussa (the "Purchase
Requirement"). In the event Just-Rite purchases less than the Purchase
Requirement during the Term, then the following conditions shall apply:

         a) If Just-Rite purchases $[----OMITTED----] in Products or less during
the Term, then Just-Rite shall pay Degussa, not more than thirty (30) days after
the expiration of the Term, a total of $2,300,000, representing a refund of the
purchase price under the Purchase Agreement, plus [----OMITTED----] of the
difference between $[----OMITTED----] and $[----OMITTED---].

         b) If Just-Rite purchases less than $[----OMITTED----] but more than
$[----OMITTED----] in Products during the Term, then Just-Rite shall pay
Degussa, not more than thirty (30) days after the expiration of the Term, an
amount equal to [----OMITTED----] of the difference between $[----OMITTED----]
and the amount of Just-Rite's purchases during the Term. The amounts payable by
Just-Rite in accordance with Sections 10(a) or (b) in the event that Just-Rite
does not satisfy the Purchase Requirement shall be referred to herein as the
"Shortfall Requirement."

         c) If Just-Rite's purchases during the Term fall within the range
contemplated in 10(b), above (i.e., more than $[----OMITTED----], but less than
$[----OMITTED----]), then Just-Rite may elect, within five business days of the
expiration of the Term, to extend the Term for one additional period of two
years (the "Extended Term"). During the Extended Term, Just-Rite may "earn back"
an amount up to the Shortfall Requirement owed under the calculation described
in Section 10(b), above. The "earn back" shall be earned by way of a commission
(the "Commission") of [----OMITTED----] of the amount by which Just-Rite's
purchases during the Extended Term exceeds two times the annual average of
purchases during the Term. At the end of the Extended Term, Just-Rite shall
continue to be obligated to pay the difference between the Commission and the
Shortfall Requirement set forth in Section 10(b), above.

         Open orders, not filled by Degussa on account of non-payment or other
failures by Just-Rite to fulfill its obligations hereunder shall not be counted
toward the Purchase Requirement. Orders made by Just-Rite which are not
fulfilled by Degussa when Just-Rite is not in default hereunder shall count
toward the Purchase Requirement, provided that such unfilled orders shall have a
thirty-day lead time and cannot represent more than four percent (4%) of the
Purchase Requirement.

                                       3

<PAGE>

         11. COMPLIANCE WITH THE LAWS. Each Party agrees to comply with all
applicable laws and regulations relating to the manufacture, sale and
distribution of Products.

         12. INDEPENDENT CONTRACTOR. In performing any services hereunder,
Just-Rite shall operate as an independent contractor. This Agreement shall not
be deemed to create or constitute a fiduciary relationship, partnership or joint
venture between Degussa and Just-Rite. Neither party hereto shall have any
authority to make contracts in the name of, or be binding on, the other party or
to otherwise pledge the other party's credit.

         13. GOVERNMENTAL APPROVALS. Each party shall be responsible for their
respective governmental approvals related to the manufacture, distribution and
sale of Products within the Territory.

         14. TERM.

             (a) Term. This Agreement shall commence on the Effective Date, and
shall terminate at the end of three (3) years (the "Term"), unless extended in
accordance with Section 10 herein (the "Extended Term") or otherwise terminated
pursuant to the provisions hereof.

             (b) Automatic Extensions. This Agreement shall be automatically
extended for successive one (1) year periods at the end of the initial and each
extended Term, unless either party provides written notice of termination to the
other party at least one hundred twenty (120) days prior to the expiration of
the initial or such extended term, respectively.

             (c) Termination by Degussa. Degussa may terminate this Agreement
prior to the end of the Term hereof, upon one hundred twenty (120) days written
notice for any default upon Just-Rite's failure to cure any default of any term,
provision or obligation of this Agreement within such notice periods.

             (d) Termination by Just-Rite. Just-Rite may terminate this
Agreement prior to the end of the Term hereof upon one hundred twenty (120) days
written notice for any default upon Degussa's failure to cure any default of any
term, provision or obligation of this Agreement within such notice periods.

             (e) Liability upon Default. Except as otherwise set forth in the
Purchase Agreement, upon termination, the non-defaulting party shall not have
any further liability to the defaulting party, except any obligations or
liabilities, if any, which accrued before the termination date.

             (f) Post Termination. Upon termination of this Agreement, all
rights of Just-Rite to use the Tradename shall terminate, except for the
completion of orders and contracts already made and to sell the remaining
balance of Product Just-Rite has in inventory as of the date of the termination.
All Degussa property in the possession of Just-Rite shall be returned to Degussa
upon the effective date of such termination. All other obligations of the
parties that are intended to survive the termination of this Agreement shall
remain in full force and effect.

                                       4

<PAGE>

         15. PRODUCT STANDARDS. Degussa agrees and acknowledges the importance
of maintaining the Product standards and quality of production as exist on the
date hereof. In accordance therewith Degussa agrees to maintain the Products
standards and to support the Tradename in a commercially reasonable manner. Such
Product standards shall include maintenance of all existing approvals of all
applicable building code within the Territory and enhancing Product Standards to
meet all other building codes that may arise hereafter similar to the
enhancements on Other Product Lines.

         16. CLAIMS AND WARRANTIES.

             (a) Degussa warrants to Just-Rite that the Products to be sold
pursuant to the terms of this Agreement will at the time of delivery conform to
the published specifications applicable to the Products (the "Specifications").
Degussa reserves the right to modify, change or alter the specifications as it
deems reasonably appropriate or necessary. Degussa warrants that the Products
which are to be sold pursuant to the terms of this Agreement will be free from
defects in the manufacture of material and will perform as stated by Degussa, if
used in accordance with Degussa's published specifications applicable to the
Product or Products sold, and the purpose for which the Products are intended to
be used, if sold and used prior to their respective shelf expiration dates.
Degussa further warrants that the Products will be manufactured in accordance
with applicable federal, state and local laws, regulations and orders. Degussa
disclaims all responsibility or liability with respect to, or arising from, any
circumstances not related solely or principally to the manufacture of the
Products. Degussa reserves the right to have the true cause of any claimed
defect determined by accepted industry test methods. Any attempt to remedy or
correct a claimed defect by persons or entities not authorized to perform such
work by Degussa shall void this warranty.

             (b) THE FOREGOING WARRANTY IS GIVEN IN LIEU OF ALL OTHER WARRANTIES
AND GUARANTIES, EITHER EXPRESS OR IMPLIED, INCLUDING THE WARRANTY OF
MERCHANTABILITY AND/OR FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT SHALL
DEGUSSA BE LIABLE OR OBLIGATED FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES,
REGARDLESS OF THE THEORY OF LIABILITY. IN NO EVENT SHALL THE LIABILITY OF
DEGUSSA FOR ANY BREACH OF CONTRACT OR WARRANTY EXCEED THE PURCHASE PRICE FOR THE
PRODUCTS IN QUESTION.

             (c) All claims made pursuant to this warranty must be received in
writing by Degussa within a reasonable period of time after the date the defect
was discovered, or through the exercise of reasonable inspection should have
been discovered, but in no event shall any claim be recognized based on a
claimed defect outside the time frame expressly set forth in the written
warranty.

                                       5

<PAGE>

             (d) If Just-Rite or its customer elects to use a Products in an
application other than as recommended in writing by Degussa for such Products,
then and in such event Degussa shall have no responsibility, obligation or
liability in that regard.

             (e) Notwithstanding anything herein to the contrary, Degussa shall
provide express written warranties comparable to Degussa's warranties for its
Other Product Lines.

         17. REPRESENTATIONS. Each Party hereby represents, warrants and
covenants to the other as follows:

             (a) RIGHT, POWER AND AUTHORITY. It has full right, power and
authority to enter into this Agreement and there is nothing which would prevent
it from performing its obligations under the terms and conditions imposed on it
by this Agreement.

             (b) BINDING OBLIGATION. This Agreement constitutes a valid and
binding obligation on it, enforceable in accordance with its terms.

             (c) NO CONSENT OF THIRD PARTIES NEEDED. No consent of any trustee
or holder of any of its indebtedness is or shall be required as a condition to
the validity of this Agreement,

             (d) NO PROCEEDINGS PENDING. There is no action or proceeding
pending or in so far as it knows or ought to know threatened against it before
any court, administrative agency or other tribunal which might have a material
adverse effect on its business or condition, financial or otherwise, or its
operation of any business.

             (e) NOT CONTRAVENE ANY LAW. Neither the execution nor the delivery
of this Agreement by it nor its fulfillment of or compliance with the terms and
provisions hereof shall contravene any provision of the laws of any
jurisdiction, including, without limitation, any statute, rule, regulation,
judgment, decree, order, franchise or permit applicable to it..

         18. INSURANCE. Degussa shall, at all times during the term of this
Agreement, maintain in force, at its sole expense, comprehensive public product
liability insurance, including insurance against claims for property damage
caused by, or occurring in conjunction with the Products. Such insurance shall
be maintained in the sum of $[----OMITTED----] for product liability. Such
insurance shall name Just-Rite as an additional insured under the policies.
Just-Rite shall, at all times during the Term of this Agreement, maintain in
force, at its sole expense, commercial general liability insurance in a coverage
amount equal to $[----OMITTED----]. Such insurance shall name Degussa as an
additional insured under the policy.

                                       6

<PAGE>

         19. INDEMNIFICATION.

             (a) Just-Rite Indemnification. Just-Rite shall indemnify and hold
Degussa, its employees and agents harmless from and against all Damages (as
hereinafter defined) arising out of or resulting of any action taken by
Just-Rite its employees or agents in furtherance of this Agreement.

             (b) Degussa Indemnification. Degussa shall indemnify and hold
Just-Rite, its affiliates and their respective employees and agents harmless
from and against all Damages arising out of or resulting from Products sold by
Just-Rite, including any claims relating to product liability or defective
Products or from the action or inaction of Degussa in furtherance of this
Agreement

             (c) Damages. Damages is defined as all actual damages, liabilities,
obligations, penalties, fines, judgments, claims, deficiencies, losses, costs,
expenses and assessments, including all attorneys' fees and costs, and interest
accruing on such Damages incurred or suffered by the Indemnitee

             (d) Claims for Indemnification. If a claim for Damages (a "Claim")
is to be made by any Party hereto (the "Indemnitee"), such Indemnitee shall give
written notice (a "Claim Notice") to the other Party (the "Indemnitor") as soon
as practicable after the Indemnitee becomes aware of any fact, condition or
event which may give rise to Damages for which indemnification may be sought
under this Agreement. In the case of a Claim involving the assertion of a claim
by a third party (whether pursuant to a lawsuit or other legal action or
otherwise, a "Third-Party Claim"), (i) the Indemnitor shall be entitled, if it
so elects, at its own cost, risk and expense, (A) to take control of the defense
and investigation of such Third-Party Claim and (B) to pursue the defense
thereof by appropriate actions or proceedings, including, without limitation, to
employ and engage attorneys of its own choice reasonably acceptable to the
Indemnitee to handle and defend the same, and (ii) the Indemnitor shall be
entitled (but not obligated), if it so elects, to compromise or settle such
claim, which compromise or settlement shall be made only with the written
consent of the Indemnitee, such consent not to be unreasonably withheld. In the
event the Indemnitor elects to assume control of the defense and investigation
of such lawsuit or other legal action in accordance with this Section 19, the
Indemnitee may, at its own cost and expense, participate in the investigation,
trial and defense of such Third-Party Claim. If the Indemnitor fails to assume
the defense of such Third-Party Claim in accordance with this Agreement within
fifteen (15) calendar days after receipt of the Claim Notice, the Indemnitee
shall (upon delivering notice to such effect to the Indemnitor) have the right
to undertake, at the Indemnitor's sole cost, risk and expense, the defense,
compromise and settlement of such Third-Party Claim on behalf of and for the
account of the Indemnitor; provided that such Third-Party Claim shall not be
compromised or settled without the written consent of the Indemnitor, which
consent shall not be unreasonably withheld. In the event the Indemnitor assumes
the defense of the claim, the Indemnitor shall keep the Indemnitee reasonably
informed of the progress of any such defense, compromise or settlement, and in
the event the Indemnitee assumes the defense of the claim, the Indemnitee shall
keep the Indemnitor reasonably informed of the progress of any such defense,
compromise or settlement. The Indemnitor shall be liable for any settlement of
any Third-Party Claim effected pursuant to and in accordance with this Section
19 and for any final judgment (subject to any right of appeal), and the
Indemnitor agrees to indemnify and hold harmless Indemnitee from and against any
and all Damages by reason of such settlement or judgment.

                                       7

<PAGE>

             (e) Suit to Enforce Rights. If Indemnitee has not received full
indemnification within thirty (30) days after making a demand and Indemnitor
does not provide written notice disputing such indemnification rights,
Indemnitee shall have the right to enforce its indemnification rights under this
Agreement by commencing an action in any court of competent jurisdiction over
the subject matter thereof and in which venue is proper, seeking an initial
determination by the court or challenging a determination by the Indemnitors
refusing indemnification. The Indemnitor shall pay to the Indemnitee for all
expenses including attorney's fees that are incurred by Indemnitee in connection
with any claim asserted against or action brought by Indemnitee for
indemnification or payment of expenses by the Indemnitor under this Agreement.

             (f) Equitable Relief. The parties agree and acknowledge that the
indemnification provided for under this Agreement is unique, and that the
parties hereto may obtain relief by way of injunction, specific performance and
such other equitable relief to which they may be entitled.

         20. CONFIDENTIALITY. The provisions of this Section 20 shall survive
the term hereof and shall be enforceable by the respective Parties by injunctive
relief, without prejudice to the non-breaching Party's other rights under this
Agreement, by law or in equity. In consideration for this Agreement and each
Party's performance hereunder, the parties agree as follows:

             (a) Each party may have access to certain of the other Party's
trade secrets, including but not limited to: business research, new product
lines and objective strategies; sales; profits; pricing methods and other
unpublished financial or pricing information; yields; facilities; methods and
systems; customer and vendor lists; detailed information regarding customer
requirements; customer preferences and modes of operation; key customer
contracts; customer business habits and customer business plans (collectively,
the "Confidential Information").

             (b) Each Party agrees and acknowledges that they may not disclose
to others or otherwise use for its own purposes, such Confidential Information
of the other Party without the prior written consent of the Party who owns such
Confidential Information; provided that such Party is free to use any
information which is already in the public domain;

             (c) Each Party agrees that the term Confidential Information shall
also apply to any trade secrets of any other company or third party with which
such possessing Party has entered into a confidentiality Agreement related to
such trade secrets to the extent such Party is bound thereby.

                                       8

<PAGE>

             (d) Upon termination of this Agreement, all Confidential
Information shall be promptly returned to the owner of such Confidential
Information, including any and all blueprints, drawings, manuals, letters,
notes, notebooks,, reports and all other materials of a secret or confidential
nature about the other Party's business or their respective parents or
affiliates.

         21. FULL DISCLOSURE. All parties hereto acknowledge and agree that they
and their respective counsel have had an opportunity to make detailed inquiry
and investigation of all relevant facts and matters related to this Agreement
and each other. Each party agrees that they have not relied upon any
representation, warranty or other information given or made by any other party
hereto and has had the right and opportunity to satisfy themselves as to all
matters related to the subject matter hereof. Each party agrees that they have
sufficient knowledge and experience, or have relied upon their own experts, in
making the decision to enter into this Agreement.

         22. REGULATORY APPROVAL. Each party agrees to take such further actions
and execute such further instruments as may be required to obtain approval or
consent of the matters contained herein by all federal, state and local
governmental authorities, if such approval or consent is required.

         23. FORCE MAJEURE. Each Party shall not be deemed to have defaulted or
failed to perform hereunder if such Party's inability to perform or default
shall have been caused by an event or events beyond the control and without the
fault of such Party, including without limitation, acts of government,
embargoes, fire, flood, hurricanes, explosions, act of God or a public enemy,
strikes, labor disputes, vandalism, civil riots or commotions, or the inability
to procure necessary raw materials, supplies, or equipment.

         24. SEVERABILITY. In the event any provision of this Agreement or the
application of such provision to any part shall be held by a court of competent
jurisdiction to be contrary to any rule of law or public policy, the remaining
provisions of this Agreement shall remain in full force and effect.

         25. JURISDICTION AND VENUE. The parties acknowledge that a substantial
portion of the negotiations, anticipated performance and execution
of this Agreement occurred or shall occur in Jacksonville, Florida and that,
therefore, each party irrevocably and unconditionally agree that:

             (a) any suit, action or legal proceeding arising out of or relating
to this Agreement and the subject matter thereof shall be brought in the courts
of record of the State of Florida in Duval County or the United States District
Court Northern District of Florida,

             (b) consents to the jurisdiction of each such court in any suit,
action or proceeding, and

                                       9

<PAGE>

               (c) waives any objection to the venue of any suit, action or
proceeding in any such court.

         26. FURTHER ASSURANCES. Each of the parties hereto agree that they will
take such further action and execute all such further papers, documents and
instruments as may be necessary or reasonably required by either of them to
carry into effect the purposes and terms, conditions and provisions of this
Agreement.

         27. NOTICE. Any and all notices required or permitted to be served
pursuant to the terms of this Agreement shall be in writing and shall be served
(a) in person, (b) by hand delivery (c) via overnight delivery service by a
nationally recognized service, (d) by facsimile, or (e) by registered or
certified mail return receipt requested and postage pre-paid, as follows:

                     Degussa:                  3550 St Johns Bluff Road
                                               Jacksonville, Florida 32225
                                               Telephone (904) 996-6345
                                               Facsimile (904) 996-6061
                                               Attention: Mr. Bill Kasik

                     With a copy to:           Degussa Corporation
                                               23700 Chagrin Blvd.
                                               Cleveland, OH 44122
                                               Attn: Associate General Counsel
                                               Fax No.: 216-839-8813

                     Just-Rite:                1259 N. W. 21st Street
                                               Pompano Beach, Florida  33069
                                               Telephone (954) 917-7665
                                               Facsimile (954) 917-2775
                                               Attention: Stephen Brown

or to such other address or facsimile number as the parties shall designate in
writing. Notice shall be deemed given three days after deposit in the United
States Mail if sent registered or certified mail or upon receipt for any other
form of delivery.

         28. ATTORNEYS' FEES. In the event of any litigation arising out of this
Agreement, the prevailing parties in such suit or proceedings shall be entitled
to receive from the non-prevailing parties all costs of prosecuting or defending
such suit or proceedings, including, without limitation, reasonable attorneys'
fees at trial and all appellate levels.

         29. SUCCESSORS AND ASSIGNS. This Agreement shall be binding upon and
inure to the benefit of all parties hereto and their respective legal
representatives, heirs, successors and permitted assigns. This Agreement may not
assigned whether by contract, operation of law or otherwise by either party
without prior written consent of the other party, provided, however Degussa may,
upon thirty (30) days' prior written notice, assign this Agreement to (a) a
purchaser of substantially all of the assets or capital stock of Degussa or (b)
an affiliate of Degussa, provided however in the event of an assignment to or
merger with an affiliate, the surviving entity shall remain liable for
performance hereunder.

                                       10

<PAGE>

         30. GOVERNING LAW. This Agreement shall be construed and enforced in
accordance with the laws of the State of Florida.

         31. CONSTRUCTION OF AGREEMENT. This Agreement shall not be construed
more strictly against one Party than against the other merely by virtue of the
fact that it may be prepared by counsel for one of the Parties, it being
recognized that all the parties hereto have contributed substantially materially
to the preparation of this Agreement.

         32. ENTIRE AGREEMENT. This Agreement contains the sole and only
agreement between the Parties with respect to the subject matter hereof and
prior discussions, writings, proposals, letters of intent, oral representations
and the like are merged herein.

         33. EXECUTION BY ALL PARTIES. This Agreement shall have no force and
effect unless and until it is executed by all of the Parties hereto.

         34. AMENDMENTS. This Agreement may be amended only by an instrument in
writing executed by the parties to be burdened hereby.

         35. COSTS AND EXPENSES. Except as otherwise provided in this Agreement,
each of the Parties to this Agreement shall bear their own expenses incurred in
connection with the negotiation, preparation, execution and closing of this
Agreement and the transaction contemplated hereby, including but not limited to
legal fees and accounting fees.

         36. REMEDIES. The right and remedies provided by this Agreement are
cumulative, and the use of any one right or remedy by any Party hereto shall not
preclude or constitute a waiver of its right to use any and all other remedies.
Such rights and remedies are given in addition to any other rights and remedies
a party may have by law, statute or otherwise.

         37. EXHIBITS. The Exhibits referred to herein are incorporated herein
by this reference.

         38. WAIVER. Any forbearance, failure or delay by any of the parties
hereto to exercise any right, power or remedy hereunder shall not be deemed a
waiver of such right, power or remedy and any single or partial exercise of any
such right, power or remedy hereunder shall not preclude the further exercise
thereof and every right, power or remedy of either party shall continue in full
force and effect unless waived specifically by an instrument in writing executed
by such party.

         39. COUNTERPARTS. This Agreement may be executed simultaneously in two
or more counterparts, each of which shall be deemed an original but all of which
together shall constitute one and the same instrument.

         40. CAPTIONS. The headings contained in this Agreement are for
reference purposes only and shall not affect the meaning or interpretation of
this Agreement.

                                       11

<PAGE>

         IN WITNESS WHEREOF, the parties have executed this Agreement as of the
date and year first above written.

                                           DEGUSSA WALL SYSTEMS, INC., a
                                           Delaware corporation

                                           By: /s/ WILLIAM KASIK
                                               ---------------------------------
                                               Name: WILLIAM KASIK
                                               Title: PRESIDENT

                                           JUST-RITE SUPPLY, INC., a Florida
                                           corporation

                                           By: /s/ HOWARD L. EHLER, JR.
                                               ---------------------------------
                                               Name: HOWARD L. EHLER, JR.
                                               Title: VICE PRESIDENT

                                       12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}]]